Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07183644 · ClinicalTrials.gov registry record · NA
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT07183644 is a NA study that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 200 participants.
The verdict
NCT07183644, a NA study, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
In this study the investigators aim to optimize Port-Wine-Birthmark (PBW) laser therapy in children in order to reduce the number of laser treatments required for clearance and improve outcomes for refractory cases. This approach also seeks to reduce the frequency with which children require general anesthesia for treatment.
Interventions
- DEVICE Pulse Dye laser
- DEVICE Pulse Dye Laser (PDL) pulse width stacking
- DEVICE Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser.
- DEVICE IPL (Intense Pulsed Light) followed by Pulse Dye Laser (PDL)
- DEVICE Cupping followed by Pulse Dye Laser (PDL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07183644
The ClinicalTrials.gov registry entry for NCT07183644 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Pulse Dye laser is the first listed.
NCT07183644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07183644 about?
NCT07183644 is a clinical study titled "Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients". In this study the investigators aim to optimize Port-Wine-Birthmark (PBW) laser therapy in children in order to reduce the number of laser treatments required for clearance and improve outcomes for refractory cases. This approach also seeks to reduce the frequency with which children require general...
What is the current status of trial NCT07183644?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-07. Estimated completion is 2028-09.
What interventions are being tested in trial NCT07183644?
The interventions under investigation include: Pulse Dye laser (DEVICE), Pulse Dye Laser (PDL) pulse width stacking (DEVICE), Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser. (DEVICE), IPL (Intense Pulsed Light) followed by Pulse Dye Laser (PDL) (DEVICE), Cupping followed by Pulse Dye Laser (PDL) (DEVICE).
Who is sponsoring clinical trial NCT07183644?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.